NCT04607603View on ClinicalTrials.gov

Efficacy of Cannabidiol in Knee Osteoarthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

October 13, 2020

Primary Completion Date

February 17, 2022

Study Completion Date

March 29, 2022

Conditions
Osteo Arthritis KneePain, Joint
Interventions
DRUG

Cannabidiol Oral Product

Cannabidiol is administered in capsules. Each capsule contains 200mg of CBD administered 3 times daily to a total of 600mg per die

DRUG

Placebo

Placebo will be administered in capsules of identical appearance to CBD capsules in 3 doses per die

Trial Locations (1)

1090

Department of Anesthesiology and Pain Medicine, Medical University Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT04607603 - Efficacy of Cannabidiol in Knee Osteoarthritis | Biotech Hunter | Biotech Hunter